NCT06415149

High-Power, Short-Duration Ablation in Treatment of Patients With Atrial Fibrillation

Name: Clinical Trial NCT06415149
Creator: People's Friendship University of Russia
Keywords: Atrial Fibrillation, catheter ablation, procedure, clinical trial, Russian Federation

People's Friendship University of Russia·ClinicalTrials.gov·procedureCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Atrial Fibrillation
Drug/Device/Intervention: catheter ablation
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: People's Friendship University of Russia
Location: Moscow, Russian Federation

Timeline & enrollment

Phase: N/A
Start date: Feb 01, 2022
End date: Mar 01, 2024
Enrollment: 185 participants

Primary outcome

interoperative outcomes,blinded period

Summary

20-45% of patients experience recurrence of atrial fibrillation (AF) after catheter ablation. The aim of this study was to evaluate efficiency and safety of high power short duration ablation in patients with atrial fibrillation and the clinical and procedural factors associated with the recurrence of AF in patients after HPSD ablation.

ICD-10 classifications

Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06415149
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06415149 through Pure Global AI's free database. This phase not specified trial is sponsored by People's Friendship University of Russia and is currently Completed. The study focuses on Atrial Fibrillation. Target enrollment is 185 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.